<DOC>
	<DOCNO>NCT01045083</DOCNO>
	<brief_summary>This exploratory study evaluate usefulness fMRI biomarker characterize response three centrally active drug placebo .</brief_summary>
	<brief_title>A Study Ability Functional Magnetic Resonance Imaging ( fMRI ) Detect Characterize Effects Two Marketed Centrally Active Drugs , Placebo , RO4917523 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Adult patient , 18 45 year age In good general health Weight &amp; # x2265 ; 120 lb ( 55 kg ) body mass index ( BMI ) 18 30kg/mÂ² Males female reproductive potential : willing use reliable method contraception Evidence clinically significant disease Medical surgical condition could alter absorption , metabolism , elimination drug Family history sudden death ventricular arrhythmia History psychiatric disorder and/or mark anxiety History glaucoma History ( include family ) motor tic diagnosis Tourette 's syndrome Active suicide ideation Contraindication MRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>